我要投票 SHINVA新华在医疗器械行业中的票数:883
· 外 推 电 报 ·
2026-01-08 20:47:37 星期四

【SHINVA新华是哪个国家的品牌?】

SHINVA新华是什么牌子?「SHINVA新华」是 山东新华医疗器械股份有限公司 旗下著名品牌。该品牌发源于山东,由创始人许尚峰在1993期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力SHINVA新华品牌出海!将品牌入驻外推网,定制SHINVA新华品牌推广信息,可以显著提高SHINVA新华产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

2002年9月,山东新华医疗器械股份有限公司在上海证券交易所上市,现为中国医疗器械行业协会会长单位。

山东新华医疗器械股份有限公司始终坚持拼搏诚信的齐鲁文化、以用户为中心的现代企业文化为企业核心价值观,用目标鼓舞士气,用发展凝聚人心,用创新提升素质,用文化打造实力,坚定不移地走健康产业之路,坚定不移地走技术创新之路,坚定不移地走资本运作之路,拥有医疗器械及装备、制药装备、医疗服务三大业务板块。

在医疗器械板块,已形成九大配置精良、技术完备的先进产品线,涵盖感染控制、放疗及影像、手术器械及骨科、手术室工程及设备、口腔设备及耗材、体外诊断试剂及仪器、生物材料及耗材、透析设备及耗材、医用环保及其他领域。

制药装备板块,由生物制药、特种输液、中药制剂、固体制剂四大工程技术中心组成,下设八个产品技术分厂和五个控股公司,集制药装备研发、制造及销售为一体。在常规制药装备生产之外,提供着“制药工艺、制药装备、制药工程”三位一体的优质服务;同时,为化学药、生物药、植物药工厂的建设提供整包服务,为客户解决一切后顾之忧。

在医疗服务领域,新华医疗持续提升着品牌竞争力和美誉度。凭借专业的投资、建设、运营及采购和服务平台,打造具有先进医疗理念、前沿科研水平、品牌经营连锁、资源有机融合的现代化医院集团。与此同时,新华医疗也在积极拓展着肾脏健康服务,利用公司专业化、集约化、连锁化的运营优势,为医院提供新技术、新管理、新模式,创建出一系列特色鲜明的肾脏病专科医院和血液透析中心,用无限的责任感和专业度,服务于广大肾病患者。未来,新华医疗,将以集团化、专业化、规范化的全新面貌,为更多患者提供完善医疗服务,成就发展健康产业之路的宏伟梦想。

公司以山东核心区域为研发、制造、营销和管理总部,同时有北京核心区域、上海核心区域。

心系健康,诚信天下。站在新的历史起点上,面对新的发展机遇,新华医疗将一如既往,与时俱进,以自信、创新和拼搏,去勇敢面对困难和挑战,为人类健康事业、为铸造中国医疗器械产业的丰碑、打造世界知名医疗器械生产企业而继续努力奋斗!

英文翻译:In September 2002, Shandong Xinhua medical device Co., Ltd. was listed on the Shanghai Stock Exchange and is now the chairman of China Medical Device Industry Association. Shandong Xinhua Medical Equipment Co., Ltd. always adheres to the Qilu culture of striving for integrity, the modern enterprise culture centered on users as the core values of the enterprise, encourages morale with goals, rallies people with development, improves quality with innovation, builds strength with culture, firmly takes the road of health industry, firmly takes the road of technological innovation, and firmly takes the road of capital The way of operation, with medical devices and equipment, pharmaceutical equipment, medical services three business sectors. In the medical equipment sector, nine advanced product lines with excellent configuration and complete technology have been formed, covering infection control, radiotherapy and imaging, surgical equipment and orthopedics, operating room engineering and equipment, oral equipment and consumables, in vitro diagnostic reagents and instruments, biomaterials and consumables, dialysis equipment and consumables, medical environmental protection and other fields. The pharmaceutical equipment sector is composed of four engineering technology centers, including biopharmaceutical, special infusion, traditional Chinese medicine preparation and solid preparation. It has eight product technology branches and five holding companies, integrating the R & D, manufacturing and sales of pharmaceutical equipment. In addition to the production of conventional pharmaceutical equipment, it provides the high-quality service of "pharmaceutical technology, pharmaceutical equipment, pharmaceutical engineering"; at the same time, it provides the whole package service for the construction of chemical medicine, biological medicine, plant medicine factories, and solves all the worries for customers. In the field of medical services, Xinhua medical continues to enhance its brand competitiveness and reputation. With professional investment, construction, operation, procurement and service platform, we will build a modern hospital group with advanced medical concept, cutting-edge scientific research level, brand management chain and organic integration of resources. At the same time, Xinhua medical is also actively expanding kidney health services, taking advantage of the company's professional, intensive and chain operation advantages to provide new technology, new management and new mode for the hospital, creating a series of distinctive kidney disease specialized hospitals and hemodialysis centers, serving the vast number of nephrotic patients with unlimited sense of responsibility and professionalism. In the future, Xinhua medical will take a new look of collectivization, specialization and standardization to provide more patients with perfect medical services and achieve the grand dream of developing health industry. The company takes the core area of Shandong Province as its R & D, manufacturing, marketing and management headquarters, and has the core areas of Beijing and Shanghai. Heart health, integrity world. Standing at a new historical starting point and facing new development opportunities, Xinhua medical will, as always, keep pace with the times, bravely face difficulties and challenges with self-confidence, innovation and hard work, and continue to strive for the cause of human health, the building of a monument of China's medical device industry and the building of a world-famous medical device manufacturer!

本文链接: https://www.waitui.com/brand/f0c49f885.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

MiniMax暗盘收涨24.61%

36氪获悉,1月9日,MiniMax预期将挂牌买卖。1月8日,MiniMax公布定价结果,将以165港元的定价上限发行。富途暗盘数据显示,MiniMax暗盘收涨24.61%,报于205.60港元。

48分钟前

迅销公布强劲营收和利润,得益于优衣库业务增长

迅销公布,得益于旗下优衣库(Uniqlo)休闲服装连锁店的全球增长加速,该公司第一财季营收和利润双双走强。这家优衣库及其他品牌的日本母公司周四表示,在截至11月的三个月里,其净利润同比增长12%,至1474.5亿日元(相当于9.405亿美元)。该净利润好于Visible Alpha在对分析师的调查中得出的1320亿日元预估值。(新浪财经)

48分钟前

快手发布关于“AI魔改”视频专项治理公告

36氪获悉,快手发文称,为进一步落实平台主体责任,响应国家广播电视总局关于“AI魔改”视频专项治理的相关要求,2026年1月1日起,快手针对“AI魔改”类违规视频开展专项治理,重点打击利用AI技术对经典影视、动画作品等进行恶意篡改、低俗解构、违规改编等行为,维护良好的内容传播秩序。截至目前平台已处置违规内容1057条。

48分钟前

工业富联:2025年半年度合计派发现金红利65.5亿元(含税),股权登记日为2026年1月15日

36氪获悉,工业富联公告,公司2025年半年度权益分派方案为每10股派送现金红利3.3元(含税),股权登记日为2026年1月15日,除权(息)日及现金红利发放日为2026年1月16日。本次利润分配方案经公司2025年第二次临时股东大会审议通过,向全体股东每10股派送现金红利3.3元(含税),以公司《2025年半年度权益分派实施公告》确定的股权登记日的总股本198.58亿股,扣除回购专用证券账户股票931.99万股后的股数,即198.49亿股为基数,合计派发现金红利65.5亿元(含税)。

48分钟前

北方长龙:拟购买顺义科技51%股份,预计构成重大资产重组

36氪获悉,北方长龙公告,公司拟以支付现金方式购买沈阳顺义科技股份有限公司(简称“顺义科技”)51%股份。如本次交易能顺利完成,顺义科技将成为公司的控股子公司。本次交易预计构成重大资产重组。

48分钟前

本页详细列出关于SHINVA新华的品牌信息,含品牌所属公司介绍,SHINVA新华所处行业的品牌地位及优势。
咨询